Infectious diseases

Prof Raina MacIntyre
Clinical Articles iconClinical Articles

COVID is an exceptional disease and was at its deadliest this year, causing more deaths in Australia between June and August 2022 than at any other time.

Prof Paul Griffin
Videos iconVideos

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains Australia’s first and only cell-based influenza vaccine, as well as the differences between influenza vaccines and why this is important to understand in order to better inform patients of the choices available (5 mins).

Prof Paul Griffin
Podcasts iconPodcasts

Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed

Prof Nancy Baxter
Podcasts iconPodcasts

The elimination of isolation periods and mask mandates, and an update on the vaccination landscape, including recently approved jabs, the bivalent vaccine, and vaccination for children

Rosalyn Page
Clinical Articles iconClinical Articles

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Expert/s: Rosalyn Page
Ben Falkenmire
Clinical Articles iconClinical Articles

GPs should plan antivirals for high- risk patients

Expert/s: Ben Falkenmire
Healthed
Clinical Articles iconClinical Articles

A new type of COVID test is set to be available from November for Australians to use at home.

Expert/s: Healthed
Dr Alexander Padiglione
Podcasts iconPodcasts

Navigating interactions... it’s easier than it first looks, and how antivirals are an important part of the management strategy to reduce the chances of severe illness and hospital admissions

Ben Falkenmire
Clinical Articles iconClinical Articles

Under national guidelines, patients with COVID at high risk of serious illness should be prescribed nirmatrelvir (Paxlovid) by GPs, with the less effective molnupiravir (Lagevrio) a second-line option.

Expert/s: Ben Falkenmire
A/Prof Nigel Crawford
Podcasts iconPodcasts

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?

Healthed
Clinical Articles iconClinical Articles

The Immunisation Coalition has launched a campaign called 'Take It From Me' to encourage Australians to get boosted.

Expert/s: Healthed
Ben Falkenmire
Clinical Articles iconClinical Articles

Vigilance is required now international travel is back, says Associate Professor Sanjaya Senanayake.

Expert/s: Ben Falkenmire